SOURCE: Renato Corporation

September 10, 2008 13:48 ET

Renato Corporation Investing in Pic-See Inc.'s Unique Patented Digital Image Processing Technology

MIAMI, FL--(Marketwire - September 10, 2008) - Renato Corporation (FRANKFURT: 4OZ) will provide an initial capital investment into Pic-See Inc.'s 3D Digital Stereoscopic Imaging Technology. After completing a thorough due diligence process, Renato Corporation is confident the investment into this dynamic patented technology will bring solid economic return on this investment. As per corporate policy Renato did not identify the company Pic-See Inc. in previous press releases. Pic-See has developed a unique patented digital image processing technology that converts two dimensional (2D) images into true three dimensional (3D) stereoscopic images. Pic-See's system, LOLA™ (Lenticular Online Assembly), enables high quality stereo still or streaming 3D images that can be rendered using conventional printing and display mediums.

Pic-See currently processes images for Ophthalmology clinics and doctors around the United States. However, Pic-See's patented system is not limited to Ophthalmology, it can process images for a variety of different x-rays such as MRIs, CT Scans and Ultrasounds. The investment plans remain on schedule and we are very excited about this opportunity. We hope to continue our business relationship with Pic-See with additional investment in the future. For more detailed information we encourage investors to visit their website at www.pic-see.com.

www.renatocorp.com

About Renato Corporation

At Renato Corporation it is the company's objective to provide diverse early detection diagnostic technologies utilizing its current experience, reputation and expertise within the international health care industry. Introducing and making available these non-invasive technologies through private health care firms and health and wellness centres in an affordable manner is our immediate focus.

The company's mission is to carefully select where these advanced diagnostic technologies will be placed to ensure unparalleled delivery of customer service and satisfaction in the field of non-invasive early detection disease diagnosis and management.

Innovative information technology platforms are enabling new models for more efficient, effective and safer healthcare delivery. It is inevitable that the economic strain on today's health care systems worldwide will realize the ever increasing need for early detection diagnostic devices and services.

Forward-Looking Statements

This press release contains "forward-looking statements" within the meaning of the Private Securities Litigation Reform Act of 1995. Statements in this release that are forward-looking statements are based on current expectations and assumptions that are subject to known and unknown risks, uncertainties, or other factors which may cause actual results, performance, or achievements of the company to be materially different from any future results, performance, or achievements expressed or implied by such forward-looking statements. Actual results could differ materially because of factors such as the effect of general economic and market conditions, entry into markets with vigorous competition, market acceptance of new products and services, continued acceptance of existing products and services, technological shifts, and delays in product development and related product release schedules, any of which may cause revenues and income to fall short of anticipated levels. All information in this release is as of the date of this release. The company undertakes no duty to update any forward-looking statement to conform the statement to actual results or changes in the company's expectations.

Contact Information

  • Contact:
    Arunas Morkunas
    Director
    Renato Corporation
    305-456-7649 head office
    416-572-2229 Canadian offices
    www.renatocorp.com